New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

To generate campus wide support for this housing development, The U must listen to their student body and create resolutions ...

Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...

Black children experience disproportionate rates of exclusion and discrimination in their schools and communities, making it difficult for them to develop ...

The result of all these changes has been a massive negative response from the online Bambu Lab community, with countless ...

Less than two weeks after the start of what has become one of the state’s most destructive natural disasters, Los Angeles ...

The Treacherous Entrance to Humboldt Bay Harbor Wrecked Ships Left and Right. Was There Any Possible Solution? ### One of the ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.